Miranda García Pablo, Casals Seoane Fernando, Gonzalez Jean-Michel, Barthet Marc, Santander Vaquero Cecilio
Aparato Digestivo, Hospital Universitario de La Princesa, España.
Gastroenterology, Hôpital Nord, France.
Rev Esp Enferm Dig. 2017 Oct;109(10):719-726. doi: 10.17235/reed.2017.4732/2016.
BACKGROUND/AIMS: Per-oral endoscopic myotomy (POEM) is a new minimally invasive technique to treat achalasia.
We performed a review of the literature of POEM with a special focus on technical details and the results obtained with this technique in patients with achalasia and other esophageal motility disorders.
Thousands of POEM procedures have been performed worldwide since its introduction in 2008. The procedure is based on the creation of a mucosal entry point in the proximal esophagus to reach the cardia through a submucosal tunnel and then perform a myotomy of the muscular layers of the cardia, esophagogastric junction and distal esophagus, as performed in a Heller myotomy. The clinical remission rate ranges from 82 to 100%. Although no randomized studies exist and available data are from single-center studies, no differences have been found between laparoscopic Heller myotomy (LHM) and POEM in terms of perioperative outcomes, short-term outcomes (12 months) and long-term outcomes (up to three years). Procedure time and length of hospital stay were lower for POEM. Post-POEM reflux is a concern, and controversial data have been reported compared to LHM. The technique is safe, with no reported deaths related to the procedure and an adverse event rate comparable to surgery. Potential complications include bleeding, perforation, aspiration and insufflation-related adverse events. Thus, this is a complex technique that needs specific training even in expert hands. The indication for this procedure is widening and other motor hypercontractil esophageal disorders have been treated by POEM with promising results. POEM can be performed in complicated situations such as in pediatric patients, sigmoid achalasia or after failure of previous treatments.
POEM is an effective treatment for achalasia and is a promising tool for other motor esophageal disorders. It is a safe procedure but, due to its technical difficulty and possible associated complications, the procedure should be performed in referral centers by trained endoscopists.
背景/目的:经口内镜下肌切开术(POEM)是一种治疗贲门失弛缓症的新型微创技术。
我们对POEM的文献进行了综述,特别关注技术细节以及该技术在贲门失弛缓症和其他食管动力障碍患者中的治疗结果。
自2008年引入以来,全球已进行了数千例POEM手术。该手术基于在食管近端创建一个黏膜入口点,通过黏膜下隧道到达贲门,然后像在Heller肌切开术中那样对贲门、食管胃交界处和食管远端的肌层进行肌切开。临床缓解率在82%至100%之间。尽管尚无随机研究,现有数据均来自单中心研究,但在围手术期结果、短期结果(12个月)和长期结果(长达三年)方面,腹腔镜Heller肌切开术(LHM)和POEM之间未发现差异。POEM的手术时间和住院时间更短。POEM术后反流是一个问题,与LHM相比,相关数据存在争议。该技术是安全的,未报告与手术相关的死亡病例,不良事件发生率与手术相当。潜在并发症包括出血、穿孔、误吸和与气腹相关的不良事件。因此,这是一项复杂的技术,即使是经验丰富的医生也需要接受专门培训。该手术的适应证正在扩大,其他运动性食管高收缩性疾病已通过POEM治疗并取得了有希望的结果。POEM可在复杂情况下进行,如儿科患者、乙状结肠型贲门失弛缓症或先前治疗失败后。
POEM是治疗贲门失弛缓症的有效方法,也是治疗其他食管动力障碍的有前景的工具。它是一种安全的手术,但由于其技术难度和可能的相关并发症,该手术应由经过培训的内镜医师在转诊中心进行。